Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wasylyk

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1983
Potentiator effect of the SV40 72-bp repeat on initiation of transcription from heterologous promoter elementsB Wasylyk, P Chambon
The Journal of Biological Chemistry|January 10, 1998
The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoterT Léveillard, B Wasylyk
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1992
Oncogenic conversion alters the transcriptional properties of etsC Wasylyk, B Wasylyk
Genes & Development|September 20, 2001
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2S Sengupta, B Wasylyk
The EMBO Journal|March 1, 1986
The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cellsC Wasylyk, B Wasylyk
Nucleic Acids Research|April 24, 1981
A T to A base substitution and small deletions in the conalbumin TATA box drastically decrease specific in vitro transcriptionB Wasylyk, P Chambon
Biochemical Society Transactions|January 1, 1975
Chemical modification of ribonucleic acid polymerase with N-bromosuccinimideB Wasylyk, A D Malcolm
Progress in Growth Factor Research|January 1, 1989
AP1, a composite transcription factor implicated in abnormal growth controlJ L Imler, B Wasylyk
Oncogene|September 1, 1994
The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence changeS L Hahn, B Wasylyk
Oncogene|July 1, 1990
Oncogene v-jun modulates DNA replicationC Wasylyk, J Schneikert, B Wasylyk
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1983
Potentiator effect of the SV40 72-bp repeat on initiation of transcription from heterologous promoter elementsB Wasylyk, P Chambon
The Journal of Biological Chemistry|January 10, 1998
The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoterT Léveillard, B Wasylyk
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1992
Oncogenic conversion alters the transcriptional properties of etsC Wasylyk, B Wasylyk
Genes & Development|September 20, 2001
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2S Sengupta, B Wasylyk
The EMBO Journal|March 1, 1986
The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cellsC Wasylyk, B Wasylyk
Nucleic Acids Research|April 24, 1981
A T to A base substitution and small deletions in the conalbumin TATA box drastically decrease specific in vitro transcriptionB Wasylyk, P Chambon
Biochemical Society Transactions|January 1, 1975
Chemical modification of ribonucleic acid polymerase with N-bromosuccinimideB Wasylyk, A D Malcolm
Progress in Growth Factor Research|January 1, 1989
AP1, a composite transcription factor implicated in abnormal growth controlJ L Imler, B Wasylyk
Oncogene|September 1, 1994
The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence changeS L Hahn, B Wasylyk
Oncogene|July 1, 1990
Oncogene v-jun modulates DNA replicationC Wasylyk, J Schneikert, B Wasylyk
Pageof 10